Clinical Trial

Evaluation of Butyrate Effect on Diarrhea

Study acronym: DBZ
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 21, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the effects of a Food Supplement containing calcium butyrate, vitamin D, and zinc, on the variation of intestinal microbiota and prevention of antibiotic-induced diarrhea, in individuals who have been prescribed antibiotic therapy. The main questions it aims to answer is: Does Dibuzin improve the microbiota composition in patients undergoing antibiotic treatment? Does Dibuzin prevent antibiotic-induced diarrhea? Participants will: - take 2 capsules/day of DBZ (1 /morning and 1 /evening, away from meals) for 14 gg. -Visit the clinic two times ( T0 and at the end), collect three fecal samples, and fill out two questionnaires 3 times.
Trial Details
NCT Number NCT06982703
Lead Sponsor University of Padova
Conditions Antibiotic-associated Diarrhea
Enrollment 50 participants
Start Date 2024-06-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-21